Post by
Georgeparros on Dec 18, 2020 2:57pm
Can't have the cake and eat it too
It is funny that people on this bullboard are whining about DrDR being CEO of another small preclinical biotech.
She greatly reduced BTI's burn rate from MD fat days and it would've been ironic that she pays herself her full market value.
She's consistent with the strategy of the company. Move preclinical programs forward, work with partners, find new partners while spending the minimum. It gives us better negotiation position and less dilution at ridiculous market prices.
I wouldnt be surprised that if deals, milestones and potentiel clinical programs come our way, we will have a full time CEO.
Comment by
Sniper007 on Dec 18, 2020 3:05pm
Hey, you wanna fight Georgeparros? :)
Comment by
Sniper007 on Dec 18, 2020 3:08pm
I retract that statement... I should've said: You wanna drop the gloves?!!
Comment by
Georgeparros on Dec 18, 2020 7:31pm
You should fear the stache, Snipe ;)